24 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35427736 | Benzo[a]pyrene inhibits myoblast differentiation through downregulating the Hsp70-MK2-p38MAPK complex. | 2022 Aug | 2 |
2 | 28806787 | Antagonism of proteasome inhibitor-induced heme oxygenase-1 expression by PINK1 mutation. | 2017 | 1 |
3 | 29285074 | Paeoniflorin inhibits proliferation of endometrial cancer cells via activating MAPK and NF-κB signaling pathways. | 2017 Dec | 1 |
4 | 25774547 | Repression of breast cancer cell growth by proteasome inhibitors in vitro: impact of mitogen-activated protein kinase phosphatase 1. | 2015 | 1 |
5 | 23261467 | Proteasome inhibitor MG132 induces NAG-1/GDF15 expression through the p38 MAPK pathway in glioblastoma cells. | 2013 Jan 25 | 4 |
6 | 23551903 | Proteasome inhibitor MG-132 induces MCPIP1 expression. | 2013 Jun | 1 |
7 | 22310719 | Proteasome inhibition-induced p38 MAPK/ERK signaling regulates autophagy and apoptosis through the dual phosphorylation of glycogen synthase kinase 3β. | 2012 Feb 24 | 2 |
8 | 22367315 | Proteasome inhibitor MG132 induces selective apoptosis in glioblastoma cells through inhibition of PI3K/Akt and NFkappaB pathways, mitochondrial dysfunction, and activation of p38-JNK1/2 signaling. | 2012 Dec | 3 |
9 | 21421692 | Mitogen-activated protein kinase inhibitors differently affect the growth inhibition and death of a proteasome inhibitor, MG132-treated human pulmonary fibroblast cells. | 2011 Dec | 3 |
10 | 20043958 | Proteasomal inhibition upregulates the endogenous MAPK deactivator MKP-1 in human airway smooth muscle: mechanism of action and effect on cytokine secretion. | 2010 Mar | 1 |
11 | 20377132 | The attenuation of MG132, a proteasome inhibitor, induced A549 lung cancer cell death by p38 inhibitor in ROS-independent manner. | 2010 | 4 |
12 | 20471510 | Treatment with p38 inhibitor partially prevents Calu-6 lung cancer cell death by a proteasome inhibitor, MG132. | 2010 Jun | 4 |
13 | 18710428 | Phosphorylation of extracellular signal-regulated kinase 1/2, p38 mitogen-activated protein kinase and nuclear translocation of nuclear factor-kappaB are involved in upregulation of matrix metalloproteinase-9 by tumour necrosis factor-alpha. | 2009 Feb | 1 |
14 | 19681889 | Inhibition of the JNK signalling pathway enhances proteasome inhibitor-induced apoptosis of kidney cancer cells by suppression of BAG3 expression. | 2009 Nov | 1 |
15 | 18064564 | Inactivation of NF-kappaB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells. | 2008 Nov | 1 |
16 | 18457675 | A p38-p65 transcription complex induced by endothelin-1 mediates signal transduction in cancer cells. | 2008 Sep | 1 |
17 | 16338464 | The kinase p38 regulates peroxisome proliferator activated receptor-gamma in human trophoblasts. | 2006 Feb-Mar | 2 |
18 | 16537561 | Specific positive and negative effects of FLIP on cell survival in human prostate cancer. | 2006 Jul | 2 |
19 | 16849502 | The antiapoptotic effect of heme oxygenase-1 in endothelial cells involves the degradation of p38 alpha MAPK isoform. | 2006 Aug 1 | 1 |
20 | 16195339 | Transcriptional regulation of cyclooxygenase-2 in response to proteasome inhibitors involves reactive oxygen species-mediated signaling pathway and recruitment of CCAAT/enhancer-binding protein delta and CREB-binding protein. | 2005 Dec | 1 |
21 | 14731112 | Proteasome inhibitors up-regulate haem oxygenase-1 gene expression: requirement of p38 MAPK (mitogen-activated protein kinase) activation but not of NF-kappaB (nuclear factor kappaB) inhibition. | 2004 May 1 | 2 |
22 | 15289872 | Inhibition of the ubiquitin-proteasome pathway activates stress kinases and induces apoptosis in renal cancer cells. | 2004 Sep | 1 |
23 | 11926998 | Inhibition of proteasomes induces accumulation, phosphorylation, and recruitment of HSP27 and alphaB-crystallin to aggresomes. | 2002 Apr | 1 |
24 | 10608813 | A short lived protein involved in the heat shock sensing mechanism responsible for stress-activated protein kinase 2 (SAPK2/p38) activation. | 1999 Dec 31 | 1 |